genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2024

COVID-19 vaccine

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA
GEN Edge

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
GEN Edge

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

Entos Expands In-House Manufacturing with GMP Facility
Bioprocessing

Entos Expands In-House Manufacturing with GMP Facility

StockWatch: MacroGenics Shares Crater after Trial Deaths
Drug Discovery

StockWatch: MacroGenics Shares Crater after Trial Deaths

Vaccine Adjuvant from Tree Bark Has Been Produced by Engineered Yeast
Bioprocessing

Vaccine Adjuvant from Tree Bark Has Been Produced by Engineered Yeast

Vaccine Developers Leverage mRNA and Other Powerful  Technologies
Infectious Diseases

Vaccine Developers Leverage mRNA and Other Powerful Technologies

StockWatch: Analysts Mixed on Moderna Despite $750M Financing, Vaccine Updates
Drug Discovery

StockWatch: Analysts Mixed on Moderna Despite $750M Financing, Vaccine Updates

Novel Thio-lipids Developed Capable of Reaching Eyes and Lungs in Animals
Infectious Diseases

Novel Thio-lipids Developed Capable of Reaching Eyes and Lungs in Animals

Plant Molecular Farming as a Novel Vaccine Production Method
Infectious Diseases

Plant Molecular Farming as a Novel Vaccine Production Method

Moderna Gets Back to Its Roots, Form Bio and Ginkgo Bioworks Team Up, and Under-the-Radar Rare Autoimmune Diseases
Bioprocessing

Moderna Gets Back to Its Roots, Form Bio and Ginkgo Bioworks Team Up, and Under-the-Radar Rare Autoimmune Diseases

123...32Page 1 of 32

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up